Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Restructuring Costs: 2013-2025

Historic Restructuring Costs for Cross Country Healthcare (CCRN) over the last 13 years, with Q3 2025 value amounting to $1.5 million.

  • Cross Country Healthcare's Restructuring Costs rose 5330.66% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 5124.84%. This contributed to the annual value of $4.3 million for FY2024, which is 6972.19% up from last year.
  • Cross Country Healthcare's Restructuring Costs amounted to $1.5 million in Q3 2025, which was up 5330.66% from $588000.0 recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Restructuring Costs registered a high of $2.5 million during Q3 2022, and its lowest value of -$1.1 million during Q2 2022.
  • Its 5-year average for Restructuring Costs is $824687.5, with a median of $850000.0 in 2021.
  • Per our database at Business Quant, Cross Country Healthcare's Restructuring Costs plummeted by 23925.0% in 2022 and then soared by 18678.16% in 2024.
  • Over the past 5 years, Cross Country Healthcare's Restructuring Costs (Quarter) stood at $800000.0 in 2021, then soared by 212.5% to $2.5 million in 2022, then crashed by 64.0% to $900000.0 in 2023, then plummeted by 68.78% to $281000.0 in 2024, then surged by 444.48% to $1.5 million in 2025.
  • Its Restructuring Costs was $1.5 million in Q3 2025, compared to $588000.0 in Q2 2025 and $301000.0 in Q1 2025.